PPIA and breast cancer: PPIA participates in the regulation of miRNA and impacts the sensitivity of breast cancer cells to doxorubicin [140] and the knockdown of RUNX, which is involved in the YAP signaling pathway, enhances sensitivity to doxorubicin in breast cancer cells [139].